跳至主要内容
临床试验/JPRN-UMIN000002214
JPRN-UMIN000002214已完成2 期

Safety and efficacy of cord blood transplantation for hematologic malignancies (OCU 9-2) - Safety and efficacy of cord blood transplantation for hematologic malignancies (OCU 9-2)

Hematology, Osaka City University, Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2009年7月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Dysfunction of major organ which meets any of the following criteria. a. T-Bil > 2.0mg/dl b. Cre > 2.0mg/dl c. EF >30% d. %VC <30%, FEV1.0% <40% or SaO2 < 50mmHg on room air (SpO2 <90%) e. AST: beyond 3 times of UNL 2. Active infection 3. Poorly controlled diabetes mellitus despite the use of insulin 4. Poorly controlled hypertention 5. Severe complications including heart failure, coronary failure, myocardial infarction within the last 3 months, liver cirrhosis and interstitial pneumonia 6. Pregnant, nursing of possible fertile woman 7. Severe mental disorder who is unlikely to be able to participate in the study 8. A history of hypersensitivity or allergy to any drugs in conditioning regimen of this transplantation 9. HIV antibody positivity 10. No indication for this study judged by physician in charge

研究者

发起方
Hematology, Osaka City University, Graduate School of Medicine

相似试验

Safety and efficacy of cord blood transplantation... | 临床试验